Singh Prahlad R. 4
Research Summary
AI-generated summary
Revvity CEO Prahlad R. Singh Exercises Options and Sells Shares
What Happened
Prahlad R. Singh (President, Chief Executive Officer and Director) exercised stock options to acquire 25,525 shares at $92.09 per share (cost ≈ $2,350,597) and conducted multiple share dispositions over Feb 4–5, 2026 that generated roughly $2.90M in proceeds. Separately, 3,421 shares were surrendered to cover tax withholding (value ≈ $345,966). Mr. Singh also received grants/awards of restricted stock units totaling 103,443 shares (26,796 + 76,647) reported as acquisitions at $0 (RSUs).
Key Details
- Transaction dates: Feb 4–5, 2026; Form 4 filed Feb 6, 2026 (timely filing).
- Option exercise: 25,525 shares exercised at $92.09 (≈ $2.35M cash paid).
- Cash sales/dispositions (open market & tax withholding): total proceeds ≈ $2.90M, individual weighted-average prices ranged about $98.98–$103.03 across multiple trades.
- Tax withholding surrender: 3,421 shares @ $101.13 = $345,966 (surrender to satisfy RSU tax) (F2).
- Market sales: several blocks (1,307; 12,186; 7,885; 3,079; 1,068 shares) at weighted-average prices shown in filing (F5–F9).
- Grants/awards reported: 26,796 and 76,647 RSUs (reported as acquisitions @ $0); RSUs/options generally vest in three equal annual installments per footnotes (F1, F3, F11).
- Sales were effected pursuant to a 10b5-1 trading plan adopted Feb 6, 2025 (F4).
- Shares owned after transaction: not specified in the excerpt — see the Form 4 for total post-transaction holdings.
Context
- This was essentially an option exercise followed by share sales (common “exercise and sell” pattern). The exercise required cash (~$2.35M) and many of the acquired shares were subsequently sold under a preplanned 10b5-1 program; some shares were surrendered to cover tax withholding on vested RSUs.
- Grants/RSUs reported here are time‑based awards with multi-year vesting (not immediate open‑market purchases), so the awards themselves do not signal an immediate buy.
- The presence of a 10b5-1 plan indicates the sales were prearranged; filing appears timely (filed two days after the reported transactions).
For full line‑by‑line details, including exact per‑trade prices and post‑transaction holdings, consult the filed Form 4 (Accession 0001193125-26-041158).